<DOC>
	<DOCNO>NCT02105519</DOCNO>
	<brief_summary>In recent year , several study reveal current influenza vaccine strategy might minimal vaccine effectiveness small effect reduce morbidity mortality end-stage renal disease population previously think . Thus , also raise question effectiveness administration influenza vaccination chronic kidney disease patient dialysis . In study , investigator aim evaluate effectiveness seasonal trivalent influenza vaccine , formulation 2013-2014 , patient different stage chronic kidney disease ( CKD ) dialysis .</brief_summary>
	<brief_title>The Effect Safety Seasonal Trivalent Influenza Vaccine Chronic Kidney Disease Patients Not Dialysis</brief_title>
	<detailed_description>The purpose study evaluate antibody response three influenza vaccine strain include licensed seasonal flu vaccine , measure method hemagglutination inhibition ( HI ) ELISA-based microneutralization ( microNT-ELISA ) assay . All participant divide 3 group : participant refuse receive vaccination , receive either one ( week 0 ) one booster vaccination ( week 0 week 4 ) . The investigator collect serum participant 5th week , 9th week , 21th week post vaccination evaluate difference immune response 3 group .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Drug-Related Side Effects Adverse Reactions</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . .Males nonpregnant female age ≥ 18 year chronic kidney disease dialysis ; 2 . .Willing able adhere visit schedule study requirement ; 3 . .Subjects read sign studyspecific inform consent . 4 . .Subjects either receive first dose 20132014 seasonal influenza vaccination . 1 . .Subject his/her family employ participated hospital ; 2 . .History hypersensitivity egg egg protein similar pharmacological effect study medication ; 3 . .Personal family history GuillainBarré Syndrome ; 4 . .An acute febrile illness within 1 week prior vaccination ; 5 . .Current upper respiratory illness , include common cold nasal congestion within 72 hour ; 6 . .Subjects influenzalike illness define presence fever ( temperature ≥ 38°C ) least two follow four symptom : headache , muscle/joint ache pain ( e.g . myalgia/arthralgia ) , sore throat cough ; 7 . .Female subject pregnant study . 8 . .Treatment investigational drug device , participation clinical study , within 3 month consent ; 9 . .Immunodeficiency , immunosuppressive treatment . 10 . .Receipt vaccine within 1 week prior study vaccination expect receipt Visit 1 ( study vaccination ) Visit 2 ( final collection blood sample ) ; 11 . .Receipt blood product , include immunoglobulin prior 3 month ; 12 . .Any severe illness need hospitalization within three month . 13 . .Underlying condition investigator ' opinion may interfere evaluation vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>trivalent influenza vaccine , chronic kidney disease</keyword>
</DOC>